The Food and Drug Administration (FDA) has announced the Commissioner’s National Priority Voucher (CNPV) Program. The idea is to have a fast-track review – as short as one to two months compared to 10 to 12 on the usual timeline – for drugs that address one or more national priorities, such as pandemic preparedness, domestic manufacturing, national security, or serious unmet medical needs.
Source: American Action Forum
Between January 2024 and August 2024, CMS fielded 90,863 “complaints that consumers had their [Exchange] plan changed without their consent,” and another 183,553 “complaints that consumers were enrolled in [Exchange] coverage without their consent.” That’s nearly 300,000 reports of fraudulent enrollment in eight months — and that’s just among the states using the federal Exchange.
The state taxes Medicaid insurers and then makes higher payments to those same insurers with that tax revenue. The higher payments enable the state to claim additional federal matching dollars.